
Cytely is a Swedish DeepTech company pioneering data-driven, smart microscopy technology that transforms traditional microscopy into an autonomous, intelligent system. Their platform combines advanced algorithms with real-time automated decision-making to capture high-fidelity quantitative microscopy data, enabling researchers to identify critical micro- and nano-level events with precision and speed. Cytely's solution integrates seamlessly with existing microscopes, providing ready-to-go assays and publication-ready results that accelerate research in biotech and pharmaceutical R&D. The company focuses on removing bottlenecks in microscopy workflows, enhancing reproducibility, and democratizing access to sophisticated imaging technology for advanced research teams worldwide. Their technology has demonstrated significant improvements in data throughput, imaging time reduction, and insight acceleration, positioning Cytely as a key innovator in smart microscopy for life sciences.

Cytely is a Swedish DeepTech company pioneering data-driven, smart microscopy technology that transforms traditional microscopy into an autonomous, intelligent system. Their platform combines advanced algorithms with real-time automated decision-making to capture high-fidelity quantitative microscopy data, enabling researchers to identify critical micro- and nano-level events with precision and speed. Cytely's solution integrates seamlessly with existing microscopes, providing ready-to-go assays and publication-ready results that accelerate research in biotech and pharmaceutical R&D. The company focuses on removing bottlenecks in microscopy workflows, enhancing reproducibility, and democratizing access to sophisticated imaging technology for advanced research teams worldwide. Their technology has demonstrated significant improvements in data throughput, imaging time reduction, and insight acceleration, positioning Cytely as a key innovator in smart microscopy for life sciences.
What they do: AI-driven SaaS that converts microscopy into autonomous, data‑driven workflows
Headquarters: Medicon Village, Lund / Malmö region, Sweden
Founded: 2022
Stage / funding: Pre-seed; early venture backing
Team size: Approximately 16 employees
Microscopy bottlenecks in life‑science research (manual targeting, low reproducibility, slow data throughput).
2022
Biotechnology
4022734 USD
Early venture backing; other investor listed as Ugly Duckling Ventures in available evidence
“Backed by Icebreaker.vc and other early‑stage investors”
| Company |
|---|